Bengaluru, India
Tricog's products, InstaECG and InstaEcho, utilize a combination of artificial intelligence and medical expertise to process digital data and deliver precise and timely diagnoses of cardiac conditions. Their vision is to become the world's most trusted diagnostic brand for predicting and detecting cardiovascular ailments.
Tricog has made significant strides, operating in 14+ countries and being utilized by over 5000+ physicians to treat 10 million+ patients, leading to the saving of 4 lakh+ lives using artificial intelligence and medical expertise. In April 2023, Tricog secured an impressive $8.50M Series B investment from notable investors including Inventus Capital Partners, SGInnovate, Sony Innovation Fund, The University of Tokyo Edge Capital, and Omron Healthcare.
